Opinion of the President – program of newborn screening in the Republic of Poland for 2019-2026
On 31 October 2024, the President of the Agency for Health Technology Assessment and Tariff System issued opinion No. 78/2024 about the draft health policy program “Program of newborn screening in the Republic of Poland for 2019-2026”, which includes a change regarding the screening panel to include testing for severe combined (combined) immunodeficiency (SCID), galactosemia and group 4 lysosomal storage diseases (Pompe disease, Fabry disease, Gaucher disease and mucopolysaccharidosis type I (MPS-I), as well as changes to the screening algorithm for cystic fibrosis